Differential requirement of perforin and IFN-γ in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen

被引:0
作者
Prévost-Blondel, A [1 ]
Neuenhahn, M [1 ]
Rawiel, M [1 ]
Pircher, H [1 ]
机构
[1] Univ Freiburg, Dept Immunol, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany
关键词
perforin; IFN-gamma; CD8 T cell; B16; melanoma; immunotherapy;
D O I
10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Perforin-mediated lysis and secretion of IFN-gamma belong to the key effector functions of CD8 T cells. To compare the anti-tumor activity of these two mechanisms, we used B16.F10 mela- noma cells (B16(GP33)) expressing the cytotoxic T cell epitope GP33 and T cell receptor transgenic (TCR-tg) mice specific for GP33 and deficient in perforin or IFN-gamma. B16(GP33) tumor cells, injected either i.v. to induce experimental metastases or s.c., were similarly controlled in both wild-type and perforin-deficient, but not in IFN-gamma-deficient TCR-tg mice. A similar result was obtained when the therapeutic efficacy of adoptively transferred TCR-tg effector cells from these mice was examined in the corresponding perforin- or IFN-gamma-deficient C57BL/6 hosts. Criss-cross experiments further revealed that IFN-gamma production by the host strongly influenced the efficiency of the adoptively transferred effector cells. In contrast to the potent ability of GP33-specific effector cells to mediate B16(GP33) tumor regression without perforin, GP33-specific memory cells, induced with recombinant vaccinia virus expressing GP33, failed to control B16(GP33) tumor growth in the absence of perforin. In conclusion, our data demonstrate a crucial role for IFN-gamma in B16(GP33) tumor cell elimination in vivo and indicate a differential requirement of perforin by effector versus memory CD8 T cells in anti-tumor immunity.
引用
收藏
页码:2507 / 2515
页数:9
相关论文
共 37 条
[11]   SELECTION OF SUCCESSIVE TUMOR LINES FOR METASTASIS [J].
FIDLER, IJ .
NATURE-NEW BIOLOGY, 1973, 242 (118) :148-149
[12]   ANTI-VIRAL PROTECTION AND PREVENTION OF LYMPHOCYTIC CHORIOMENINGITIS OR OF THE LOCAL FOOTPAD SWELLING REACTION IN MICE BY IMMUNIZATION WITH VACCINIA-RECOMBINANT VIRUS EXPRESSING LCMV-WE NUCLEOPROTEIN OR GLYCOPROTEIN [J].
HANY, M ;
OEHEN, S ;
SCHULZ, M ;
HENGARTNER, H ;
MACKETT, M ;
BISHOP, DHL ;
OVERTON, H ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (03) :417-424
[13]   T-CELL RECEPTOR ANTAGONIST PEPTIDES INDUCE POSITIVE SELECTION [J].
HOGQUIST, KA ;
JAMESON, SC ;
HEATH, WR ;
HOWARD, JL ;
BEVAN, MJ ;
CARBONE, FR .
CELL, 1994, 76 (01) :17-27
[14]   CYTOTOXICITY MEDIATED BY T-CELLS AND NATURAL-KILLER-CELLS IS GREATLY IMPAIRED IN PERFORIN DEFICIENT MICE [J].
KAGI, D ;
LEDERMANN, B ;
BURKI, K ;
SEILER, P ;
ODERMATT, B ;
OLSEN, KJ ;
PODACK, ER ;
ZINKERNAGEL, RM ;
HENGARTNER, H .
NATURE, 1994, 369 (6475) :31-37
[15]   FAS AND PERFORIN PATHWAYS AS MAJOR MECHANISMS OF T-CELL-MEDIATED CYTOTOXICITY [J].
KAGI, D ;
VIGNAUX, F ;
LEDERMANN, B ;
BURKI, K ;
DEPRAETERE, V ;
NAGATA, S ;
HENGARTNER, H ;
GOLSTEIN, P .
SCIENCE, 1994, 265 (5171) :528-530
[16]   Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice [J].
Kaplan, DH ;
Shankaran, V ;
Dighe, AS ;
Stockert, E ;
Aguet, M ;
Old, LJ ;
Schreiber, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7556-7561
[17]  
Kodama T, 1999, EUR J IMMUNOL, V29, P1390, DOI 10.1002/(SICI)1521-4141(199904)29:04<1390::AID-IMMU1390>3.0.CO
[18]  
2-C
[19]   T-CELL IMMUNITY AFTER A VIRAL-INFECTION VERSUS T-CELL TOLERANCE INDUCED BY SOLUBLE VIRAL PEPTIDES [J].
KYBURZ, D ;
AICHELE, P ;
SPEISER, DE ;
HENGARTNER, H ;
ZINKERNAGEL, RM ;
PIRCHER, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) :1956-1962
[20]   TUMOR-SELECTIVE CYTO-TOXIC EFFECTS OF MURINE TUMOR NECROSIS FACTOR (TNF) AND INTERFERON-GAMMA (IFN-GAMMA) IN ORGAN-CULTURE OF B-16 MELANOMA-CELLS AND HEART-TISSUE [J].
MAREEL, M ;
DRAGONETTI, C ;
TAVERNIER, J ;
FIERS, W .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) :470-473